Company / Depreciation & Amortization
STAAR Surgical Company Depreciation & Amortization History
FY2017-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.7M
FY2021
5-year range
$3.7M / $3.7M
FY2017-FY2021
Trend
+50.8%
vs FY2020
Sector context
#134 of 142
Health Care
What the data says
Among 142 Health Care companies, STAAR Surgical Company is in the top 6% for depreciation & amortization. Increased from $3M to $4M over the past 3 years.
Based on SEC 10-K filings.
$4M in FY2021 with a 3-year CAGR of +11.2%.
Increased from $3M to $4M over the past 3 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +11.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 142This company $3.7M Sector average $347.4M
▼
-98.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +11.2%, indicating consistent growth.
- In FY2021, depreciation & amortization increased 50.8% year-over-year.
- Ranks #134 out of 142 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $3.7M | +50.8% |
| FY2020 | $2.4M | - |
| FY2019 | - | - |
| FY2018 | $2.7M | +21.3% |
| FY2017 | $2.2M | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026